Log in to save to my catalogue

PERK: a novel therapeutic target for neurodegenerative diseases?

PERK: a novel therapeutic target for neurodegenerative diseases?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4075240

PERK: a novel therapeutic target for neurodegenerative diseases?

About this item

Full title

PERK: a novel therapeutic target for neurodegenerative diseases?

Author / Creator

Publisher

England: BioMed Central Ltd

Journal title

Alzheimer's research & therapy, 2014-05, Vol.6 (3), p.30-30, Article 30

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Identification of therapeutic targets based on novel mechanistic studies is urgently needed for neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and prion disease. Multiple lines of evidence have emerged to suggest that inhibition of the stress-induced endoplasmic reticulum kinase PERK (protein kinase RNA-like endoplasmi...

Alternative Titles

Full title

PERK: a novel therapeutic target for neurodegenerative diseases?

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4075240

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4075240

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/alzrt260

How to access this item